13F-HR filed by Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 86 holding rows worth $810,489,964.
- Accession
- 0001213900-26-056196
- Filer
- CIK 1599882
- Filed
- 2026-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 86 entries on the cover page, a total value of $810,489,964 stated on the cover page (in dollars after the unit check, H1), rows summing to $810,489,964 with VALUE read as dollars as filed, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 101137107 | COM | 625,000 | $39,218,750 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 48,100 | $37,163,984 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 33,715 | $31,010,046 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 159,760 | $26,123,955 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 336,500 | $24,167,430 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 167,750 | $23,379,318 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 41,340 | $20,319,850 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 109,100 | $20,001,303 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 43,485 | $19,417,792 | dollars as filed | |
| ALIGNMENT HEALTHCARE INC COM | 01625V104 | Stock | 1,053,450 | $18,561,789 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 36,846 | $16,985,638 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 52,375 | $16,453,083 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 47,800 | $15,706,602 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 71,575 | $15,566,847 | dollars as filed | |
| VEEVA SYS INC CL A COM | 922475108 | Stock | 85,300 | $14,983,798 | dollars as filed | |
| MCKESSON CORP COM | 58155Q103 | Stock | 16,850 | $14,581,316 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 75,890 | $14,347,005 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 145,000 | $13,393,650 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 100,841 | $13,284,793 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 163,000 | $13,053,040 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 24,050 | $12,589,454 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 45,500 | $12,311,845 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 475,000 | $11,879,750 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 207,000 | $11,693,430 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 112,000 | $11,499,040 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 34,465 | $11,403,435 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 233,000 | $11,177,010 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 63,800 | $10,783,476 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 51,600 | $10,319,484 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 54,000 | $10,190,340 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 720,000 | $9,993,600 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 155,000 | $9,851,800 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 32,300 | $9,455,825 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 144,500 | $9,060,150 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 84,000 | $9,043,440 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 53,000 | $9,038,620 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 379,250 | $8,859,280 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 92,605 | $8,554,850 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 255,500 | $8,513,260 | dollars as filed | |
| PENNANT GROUP INC | 70805E109 | COM | 275,399 | $8,394,162 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 81,200 | $8,318,940 | dollars as filed | |
| WAYSTAR HLDG CORP | 946784105 | COM | 342,566 | $8,259,266 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 1,438,625 | $7,984,369 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 90,000 | $7,798,500 | dollars as filed | |
| OSCAR HEALTH INC | 687793109 | CL A | 660,000 | $7,570,200 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 2,055,327 | $7,214,198 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 263,071 | $7,126,593 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 92,900 | $6,975,861 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 81,627 | $6,850,138 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 90,600 | $6,727,956 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 75,000 | $6,312,750 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 128,100 | $6,174,420 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 27,000 | $5,705,370 | dollars as filed | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 56,263 | $5,442,320 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 15,200 | $5,348,120 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 160,000 | $5,206,400 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 313,500 | $4,859,250 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 133,250 | $4,711,720 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 26,000 | $4,485,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 239,500 | $4,464,280 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 16,675 | $4,307,486 | dollars as filed | |
| DOXIMITY INC CL A | 26622P107 | Stock | 183,808 | $4,282,726 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 59,000 | $4,245,050 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 199,000 | $3,820,800 | dollars as filed | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 274,676 | $3,776,795 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 360,000 | $3,582,000 | dollars as filed | |
| COOPER COS INC | 216648501 | COM | 50,000 | $3,575,000 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 87,500 | $3,507,875 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 15,000 | $3,430,950 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 18,052 | $3,422,659 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 14,000 | $2,937,760 | dollars as filed | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 25,000 | $2,849,500 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 83,000 | $2,702,480 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 985,000 | $2,698,900 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 85,724 | $2,584,579 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 305,000 | $2,583,350 | dollars as filed | |
| STERIS PLC SHS USD | G8473T100 | Stock | 11,500 | $2,542,995 | dollars as filed | |
| VERICEL CORP | 92346J108 | COM | 70,000 | $2,251,900 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 271,500 | $2,207,295 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 8,000 | $2,134,000 | dollars as filed | |
| BRIGHTSPRING HEALTH SVCS | 10950A106 | COM | 50,000 | $2,130,500 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 28,000 | $1,628,200 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 7,500 | $1,285,725 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 70,000 | $763,000 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 70,000 | $761,600 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 115,113 | $608,948 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-26-056196 | this filing | 2026-05-14 | acceptance time not in the bulk data set |